You searched for "ORL"

715 results found

In conversation with Professor Eugene Myers: My life in ENT

In a series of interviews, former Chairman of the Editorial Board for ENT & audiology news, Professor Patrick J Bradley, speaks with eminent otolaryngologists who have retired (or are about to retire) from practice. Our first is with Professor Gene...

Systemic agents in thyroid cancer

For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...

Singing after laryngectomy: Shout at Cancer

Thomas Moors is an ENT junior doctor with a background in music and singing. Combining these interests, he has set up a charity to help patients who have had a laryngectomy. He has achieved considerable public attention, and he tells...

In conversation with Miss Sujata De: Chair of the ESPO 2023 Local Programme Committee

Su De is one of the UK’s most prominent paediatric ORL surgeons, and has a leading role in planning ESPO 2023. Hannah Emerson caught up with Su recently to explore some of her thoughts and her plans for ESPO. You’ve...

In conversation with Shusheng Gong and Shahed Quraishi on ENT Masterclass<sup>®</sup> China

ENT Masterclass® China was a landmark event that brought an international training resource to Beijing. Profs Shusheng Gong and Shahed Quraishi discuss the organisation of this event, the training pathway in China, and the setup of a typical ENT academic...

Prof Metin Önerci – ENT in Central Asia

Our Global Ambassador covering the Eurasia region is Prof Metin Önerci. We wanted him to shed some light on ENT in the countries of Central Asia – this is an area of the world that we in the west hear...

From the editor Mar/Apr 2025

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk For Ent & Audiology News Mar/Apr 2025, we feature a wonderful interview with one of the most respected and...

Setting up a robotic surgical practice: view from India

Transoral robotic surgery has an established role in head and neck cancer surgery. But how easy is it to set up a service in a resource-constrained environment? Gouri Pantvaidya and Ameya Pai give us a view from the Indian subcontinent....

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Preoperative planning of the surgical patient

This article covers the need to effectively optimise patient status preoperatively to help maximise postoperative outcomes. The article is well written and emphasises close liaison with anaesthetic colleagues particularly regarding airway assessment and nausea and vomiting. As is becoming common...

Role of oral and intranasal steroids in the management of otitis media with effusion

Inflammation is considered an important factor in the pathogenesis and continuation of otitis media with effusion. Theoretically, this may support the use of steroids, oral or intranasal in the management of this condition. This study comprised three well matched groups...

Investigation of the role of KPNA2 biomarker in oral SCC invasiveness

This edition of Head and Neck has a strong focus on studies using immunohistochemistry (IHC) to elucidate potential roles of various cell-signalling molecules in both HNSCC and thyroid cancer. The ‘cellular-protein heavy’ title of this article may be off-putting to...